Astellas PharmaJP394240000745034503
Astellas Pharma
JP3942400007
4503
4503
There is no discussion about the security yet. Share your thoughts now!
Financials
Market Cap
$22.05B5Y beta
0.67EPS (TTM)
$0.0835Free Float
1.79BP/E ratio (TTM)
145.87Revenue (TTM)
$11.97BEBITDA (TTM)
$1.85BFree Cashflow (TTM)
-$304.57MPricing
52W span
$10.15$15.68
Analyst Ratings
The price target is $13.78 and the stock is covered by 14 analysts.
Buy
8
Hold
5
Sell
1
Information
14754Biotechnology & DrugsHealth Care
Astellas Pharma Inc is a Japan-based company mainly engaged in the research, development, manufacture and sales of pharmaceutical products. The Company mainly operates Pharmaceutical Products business segment. The main products include XTANDI, BETANIS, MIRABETRIC, BETMIGA and new products ZOSPATA, EVERENZO and ENHOLTUMAB VEDOTIN, among others.
Identifier
ISIN
JP3942400007
Primary Ticker
4503